Accelerator
$1.5m
Vaccine Platform Secures Funds Against Mosquito Threats
UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.